Ellume Limited

Ellume Pty Ltd

Respirio Pty Ltd

Sean Andrew Parsons

Scott Robert Fry

Michael Stuart Hazell

Andrea Ranzoni

Geoff Bywater

David Lara

Tim Ian Spink

Steven David Dahl

Jennifer Maschmann

Kon Euan Gerard Wong

Stephen Wilson

Mark Gilroy

Rhiannon McBean

Stephen Robert Wilson

An assay device is disclosed comprising a housing and a test portion, electronic circuitry and an optical assembly each a least partially located in the housing. The test portion comprises one or more test zones adapted to receive an analyte and a fluorescent label associated with the analyte, the fluorescent label being excitable by excitation light and adapted to emit emission light upon excitation by excitation light. The electronic circuitry comprises one or more light sources and one or more light detectors. The optical assembly comprises one or more excitation light guides adapted to guide excitation light from the one or more light sources to the one or more test zones, and/or one or more emission light guides adapted to guide emission light from the one or more test zone to the one or more light detectors.

Assay device employing fluorescent labels

Sample collection device

Apparatus is disclosed for identifying at least a first target condition in a human or animal body. The apparatus comprises one or more test portions for identifying a first analyte in a biological sample from the body, the first analyte providing a marker of the first target condition, and a second analyte in the biological sample, the second analyte being different from the first analyte. The apparatus is configured to identify the first target condition in the body based on the identification of both the first and second analytes. In one embodiment, the first target condition is pregnancy, the first analyte is human chorionic gonadotropin (hCG) and the second analyte is luteinizing hormone (LH).

Diagnostic devices and methods

The present disclosure relates to devices and methods for identifying conditions in a human or animal body, such as pregnancy or ovulation. For example, the present disclosure relates to devices and methods for identifying pregnancy or ovulation, which devices and methods are adapted to mitigate the 'hook effect', thereby improving accuracy of the devices and methods.

Diagnostic devices and methods for mitigating hook effect and use thereof

Diagnostic test stick

An assay device is disclosed comprising a housing () and a test portion (), electronic circuitry () and an optical assembly (), each at least partially located in the housing (). The test portion () comprises one or more test zones (E,F) adapted to receive an analyte () and a fluorescent label associated with the analyte, the fluorescent label being excitable by excitation light and adapted to emit emission light upon excitation by excitation light. The electronic circuitry () comprises one or more light sources () and one or more light detectors (). The optical assembly (-) comprises one or more excitation light guides () adapted to guide excitation light from the one or more light sources () to the one or more test zones (), and/or one or more emission light guides () adapted to guide emission light from the one or more test zones () to the one or more light detectors (). The sets of emission light guides () and excitation light guides () may also take the form of individual integral one-piece light guide units where the emission light guide unit rests within the excitation light guide unit.

Diagnostic test device

A device () is provided that is configured to indicate the presence or absence of one or more biological entities in a biological sample. The device comprises a sampling portion (), the sampling portion comprising flexible material adjustably conformable to a part of a human or animal body, at least a portion of the sampling portion being absorbent and configured to receive a biological sample directly from the body; and a test portion () in fluid engagement with the sampling portion, the test portion comprising one or more test zones (). The sampling portion and test portion are configured such that at least a portion of the sample received by the sampling portion is transferable to the test portion such as to contact one or more of the test zones, and wherein each test zone is configured to indicate the presence or absence of one or more biological entities in the sample.

Sampling and testing device for the human or animal body

Optical element for assay device

Sampling and testing device

Growing community of inventors

East Brisbane, Australia

Sean Andrew Parsons